Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology

• Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans (13 December 2017)
• Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus (July 2019)
• Ecology and transmission of Buruli ulcer disease: a systematic review. (2010 Dec 14).

Clinical Information and Management

• Revisiting buruli ulcer. (2015 Nov).
• Epidemiology and management of Buruli ulcer. Expert Review of Anti-infective Therapy. (2014 Jul 1).
• Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection. (2011 Jan).
• Buruli ulcer: emerging from obscurity. (2006 Jun 3).
• Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. (2005 Apr 26).

Treatment and ‘Paradoxical Responses’

• Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer (18 December 2018)
• Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. (2014 Mar 17).
• Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection. (2011 Dec 7).
• Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). (2010 Jul 6).
• " Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure. (2009 Nov 16).
• Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrobial Agents and Chemotherapy. (2005 Aug 1).